news
Sanofi Pasteur’s Dengvaxia approved in the Philippines
Dengvaxia is the first vaccine licensed for the prevention of dengue in the world...
List view / Grid view
Sanofi Pasteur
news
First shipment of ShanIPV to be distributed in India
1 December 2015 | By Victoria White
These first vaccine doses will be available to implement one dose of IPV for all infants in the country...
news
Sanofi Pasteur’s dengue vaccine candidate safely protects pre-adolescents
28 July 2015 | By Victoria White
New data analyses provide a comprehensive picture of the potential public health impact of vaccinating pre-adolescents and adults against dengue...
news
Sanofi announces new Global Business Unit structure
15 July 2015 | By Victoria White
Sanofi plans to evolve its business with the creation of five Global Business Units: General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial.
news
Sanofi Pasteur ships first 2015-2016 seasonal influenza vaccine doses in US
14 July 2015 | By Victoria White
The FDA has released the first doses of Sanofi Pasteur’s Fluzone influenza vaccine for shipment for the 2015-2016 influenza season in the US...
news
GARDASIL 9 HPV vaccine approved in the European Union
17 June 2015 | By Victoria White
GARDASIL 9 is approved in the EU for active immunisation against premalignant lesions and cancers affecting the cervix, vulva, vagina or anus...
news
Sanofi Pasteur announces FDA approval of Quadracel DTaP-IPV vaccine for children aged 4 to 6
26 March 2015 | By Victoria White
Sanofi Pasteur announces the FDA approval of Quadracel for immunisation against diphtheria, tetanus, pertussis and poliomyelitis in children aged 4 to 6...
news
New Genital Herpes vaccine entrants require improved efficacy to compete, says GlobalData analyst
31 October 2014 | By GlobalData
While the collaboration between Sanofi Pasteur (Sanofi) and Immune Design to develop a genital herpes vaccine presents a strong scientific foundation and difficult-to-match financial clout, the partnership needs to create a product with better clinical performance to compete with more advanced pipeline vaccine candidates, says an analyst with research and…
news
Sanofi Pasteur announces publication of positive data for Fluzone® high-dose vaccine in The New England Journal of Medicine
14 August 2014 | By Sanofi
Sanofi Pasteur announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone® High-Dose (Influenza Vaccine) was more efficacious in preventing influenza...
news
First ever dengue vaccine candidate to show efficacy against dengue fever and dengue haemorrhagic fever in Asia
11 July 2014 | By Sanofi
Sanofi Pasteur, the vaccines division of Sanofi announced the publication in The Lancet of the detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia...
news
Sanofi Pasteur allies with SK Chemical Co. of South Korea on pneumococcal conjugate vaccine
19 March 2014 | By Sanofi
A long-term strategic business collaboration to co-develop and commercialize an innovative vaccine against pneumococcal infection to address global public-health needs...
news
Menomune® is the first quadrivalent meningococcal vaccine prequalified by the WHO
3 September 2013 | By Sanofi
Prequalification makes the vaccine eligible for purchase by United Nations Agencies...
news
Sanofi Pasteur’s Fluzone High-Dose vaccine significantly more effective than standard dose Fluzone vaccine in preventing influenza
26 August 2013 | By Sanofi Pasteur
“We are pleased that this study demonstrates the superior relative efficacy of Fluzone High-Dose vaccine..."
news
New four-strain influenza vaccine from Sanofi Pasteur now licensed by FDA for broad age range of children and adults
10 June 2013 | By Sanofi Pasteur
“Sanofi Pasteur is committed to providing new immunization options..."
news
Sanofi Pasteur to provide 1.7 billion doses of oral polio vaccine from 2013 to 2017 for polio eradication
24 April 2013 | By Sanofi Pasteur
Company also expands injectable polio vaccine production capacity...
